PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, announced today that it has finalized the previously announced transaction to acquire Owen Mumford Holdings Limited (“Owen Mumford”), a privately held UK-based leader in medical device and drug delivery technology innovation and manufacturing.
